Skip to content

Clinical trials

Phase 3 Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 3 Country / region: Germany Clear all

138 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20043
20053
20064
20077
20088
20098
201012
20116
20123
20137
20144
20158
20166
20173
20189
20199
20208
20213
20223
20236
20243
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Terminated25
Active, not recruiting22
Recruiting11
Unknown status6
Not yet recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie13
Novartis Pharmaceuticals12
AstraZeneca7
Amgen6
Bayer6
Charite University, Berlin, Germany4
GlaxoSmithKline4
Hoffmann-La Roche4
Pfizer3
Sanofi3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms138
Neoplasm Metastasis19
Neoplasms by Site15
Breast Neoplasms13
Carcinoma, Non-Small-Cell Lung10
Carcinoma9
Recurrence9
Adenocarcinoma8
Carcinoma, Renal Cell8
Colorectal Neoplasms7

Trials

Showing 1 to 25 of 138. Each trial links to its page on Pharma Observatory.

38 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.